The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor

Neuropharmacology

Volumn 39, Issue 11, 2000, Pages 2044-2053

  Rettinger, Jürgen ^a   Schmalzing, Günther ^a   Damer, Susanne ^a   Müller, Gregor ^b   Nickel, Peter ^b   Lambrecht, Günter ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Antagonism; Electrophysiology; Ion channel; NF279; P2X receptor; Suramin analogue

Indexed keywords

8,8' [CARBONYLBIS(IMINO 4,1 PHENYLENECARBONYLIMINO 4,1 PHENYLENECARBONYLIMINO)]BIS(1,3,5 NAPHTHALENETRISULFONIC ACID); NAPHTHALENESULFONIC ACID DERIVATIVE; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; XENOPUS LAEVIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; FEMALE; HUMANS; RATS; RECEPTORS, PURINERGIC; RECEPTORS, PURINERGIC P2; SURAMIN; XENOPUS LAEVIS;

EID: 0033841633     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00022-8     Document Type: Article

References (41)

1. Abbracchio M.P., Burnstock G. Purinergic signalling: pathophysiological roles. Japanese Journal of Pharmacology. 78:1998;113-145.
2. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. British Journal of Pharmacology. 14:1959;48-58.
3. Brake A.J., Wagenbach M.J., Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371:1994;519-523.
4. Bültmann R., Wittenburg H., Pause B., Kurz G., Nickel P., Starke K. P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn-Schmiedeberg's Archives of Pharmacology. 354:1996;498-504.
5. Chen C.C., Akopian A.N., Sivilotti L., Colquhoun D., Burnstock G., Wood J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:1995;428-431.
6. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. Journal of Neuroscience. 16:1996;2495-2507.
7. Damer S., Niebel B., Czeche S., Nickel P., Ardanuy U., Schmalzing G.et al. NF279: a novel potent and selective antagonist of P2X receptor-mediated responses. European Journal of Pharmacology. 350:1998;R5-R6.
8. Dilger J.P., Brett R.S. Direct measurement of the concentration- and time-dependent open probability of the nicotinic acetylcholine receptor channel. Biophysical Journal. 57:1990;723-731.
9. 4 receptor reveals pharmacological differences to the rat homologue. Molecular Pharmacology. 51:1997;109-118.
10. Gloor S., Pongs O., Schmalzing G. A vector for the synthesis of cRNAs encoding Myc epitope-tagged proteins in Xenopus laevis oocytes. Gene. 160:1995;213-217.
11. 5 isoforms. Molecular Pharmacology. 56:1999;720-727.
12. 7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Molecular Pharmacology. 54:1998;22-32.
13. 1 receptors. Journal of Medicinal Chemistry. 41:1998;2201-2206.
14. Kassack M., Nickel P. Rapid, highly sensitive gradient narrow-bore high-performance liquid chromatographic determination of suramin and its analogues. Journal of Chromatography B. 686:1996;275-284.
15. Kenakin T.P. Pharmacologic Analysis of Drug-Receptor Interaction. 1993;Raven Press, New York.
16. 7 receptors. European Journal of Pharmacology. 387:2000;245-252.
17. + ATPase in the membrane of oocytes of Xenopus laevis. Journal of Membrane Biology. 91:1986;43-51.
18. Lambrecht G. Design and pharmacology of selective P2-purinoceptor antagonists. Journal of Autonomic Pharmacology. 16:1996;341-344.
19. Lambrecht G., Ardanuy U., Bäumert G., Bo X., Hoyle C.H.V., Nickel P.et al. Design and pharmacological characterization of selective P2-purinoceptor antagonists. Giardina D., Piergentili A., Pigini M. Perspective in Receptor Research. 1996;337-350 Elsevier Science BV, Amsterdam.
20. Lambrecht G., Damer S., Niebel B., Czeche S., Nickel P., Rettinger J.et al. Novel ligands for P2 receptor subtypes in innervated tissues. Progress in Brain Research. 120:1999;107-117.
21. 6 channel subunits coassemble into a novel heteromeric ATP receptor. Journal of Neuroscience. 18:1998;7152-7159.
22. 5 subunits. Journal of Biological Chemistry. 274:1999;15415-15419.
23. Leff P. Potential errors in agonist dissociation constant estimation caused by desensitization. Journal of Theoretical Biology. 121:1986;221-232.
24. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature. 377:1995;432-435.
25. Lewis C.J., Surprenant A., Evans R.J. 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP) - a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. British Journal of Pharmacology. 124:1998;1463-1466.
26. Methfessel C., Witzemann V., Takahashi T., Mishina M., Numa S., Sakmann B. Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pfluegers Archiv. 407:1986;577-588.
27. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO Journal. 17:1998;3016-3028.
28. Nickel P., Haack H.J., Widjaja H., Ardanuy U., Gurgel C., Düwel D.et al. Potentielle Filarizide, Suramin-Analoge. Arzneimittel-Forschung/Drug Research. 36:1986;1153-1157.
29. North R.A. Families of ion channels with two hydrophobic segments. Current Opinion in Cell Biology. 8:1996;474-483.
30. 3 receptors. Journal of Neuroscience. 17:1997;6529-6533.
31. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacological Reviews. 50:1998;413-492.
32. Rassendren F., Buell G., Newbolt A., North R.A., Surprenant A. Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO Journal. 16:1997;3446-3454.
33. 1 receptor-selective antagonist. Naunyn-Schmiedeberg's Archives of Pharmacology. 359(Suppl.):1999;R31.
34. Schmalzing G., Kröner S., Schachner M., Gloor S. The adhesion molecule on glia (AMOG/β2) and α1 subunits assemble to functional sodium pumps in Xenopus oocytes. Journal of Biological Chemistry. 267:1992;20212-20216.
35. Soto F., Garcia-Guzman M., Stühmer W. Cloned ligand-gated channels activated by extracellular ATP (P2X receptors). Journal of Membrane Biology. 160:1997;91-100.
36. Soto F., Lambrecht G., Nickel P., Stühmer W., Busch A.E. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors. Neuropharmacology. 38:1999;141-149.
37. Starke K., von Kugelgen I., Driessen B., Bültmann R. ATP release and its prejunctional modulation. Ciba Foundation Symposia. 198:1996;239-249.
38. Torres G.E., Haines W.R., Egan T.M., Voigt M.M. Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel. Molecular Pharmacology. 54:1998;989-993.
39. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A.et al. A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature. 371:1994;516-519.
40. 2/3 receptors. Molecular Pharmacology. 53:1998;969-973.
41. Ziyal R., Ziganshin A.U., Nickel P., Ardanuy U., Mutschler E., Lambrecht G.et al. Vasoconstrictor responses via P2X-receptors are selectively antagonized by NF023 in rabbit isolated aorta and saphenous artery. British Journal of Pharmacology. 120:1997;954-960.